Adefovir and lamivudine in combination compared with adefovir monotherapy in HBeAg-negative adults with chronic hepatitis B virus infection and clinical or virologic resistance to lamivudine: A retrospective, multicenter, nonrandomized, open-label study

Clinical Therapeutics

Volumn 30, Issue 2, 2008, Pages 317-323

  Pellicelli, Adriano M ^a   Barbaro, Giuseppe ^b   Francavilla, Ruggiero ^c   Romano, Mario ^d   Barbarini, Giorgio ^e   Mazzoni, Ettore ^f   Mecenate, Fabrizio ^g   Paffetti, Amerigo ^h   Barlattani, Angelo ⁱ   Struglia, Carlo ^a   Villani, Roberto ^a   Nauri, Leone ^a   Nosotti, Lorenzo ^j   Armignacco, Orlando ^k   Ferri, Fabrizio ^k   Camporiondo, Maria Pia ^a   Soccorsi, Fabrizio ^a  

^a SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c Department of Infectious Disease Hospital ^*  (Italy)

^d SANDRO PERTINI HOSPITAL   (Italy)

^e FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^f FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^g Liver Unit Villa Betania Hospital   (Italy)

^h POLICLINICO UMBERTO I   (Italy)

ⁱ San Giacomo Hospital   (Italy)

^j SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

^k BELCOLLE HOSPITAL   (Italy)

more..

Author keywords

adefovir; clinical resistance; hepatitis B virus; lamivudine; virologic resistance

Indexed keywords

ADEFOVIR; ALANINE AMINOTRANSFERASE; CREATININE; LAMIVUDINE;

ABSENCE OF SIDE EFFECTS; ADD ON THERAPY; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHRONIC HEPATITIS; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFICACY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OPEN STUDY; RETROSPECTIVE STUDY; SIDE EFFECT; VIRUS LOAD;

ADENINE; ADULT; AGED; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; DNA, VIRAL; DRUG RESISTANCE, VIRAL; DRUG THERAPY, COMBINATION; FEMALE; HEPATITIS B; HEPATITIS B E ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; LAMIVUDINE; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; PHOSPHONIC ACIDS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; VIRAL LOAD;

EID: 41549084159     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2008.02.012     Document Type: Article

References (17)

1. Lok A., and McMahon B. Chronic hepatitis B: Update of recommendations. Hepatology 39 (2004) 857-861
2. Lampertico P., Viganó M., Manenti E., et al. Adefovir rapidly suppresses hepatitis B in HBeAg-negative patients developing genotypic resistance to lamivudine. Hepatology 42 (2005) 1414-1419
3. Hadziyannis S., Papatheodoridis G., Dimou E., et al. Efficacy of long-term lamivudine monotherapy in patients with hepatitis B e antigen-negative chronic hepatitis B. Hepatology 32 (2000) 847-851
4. Papatheodoridis G., Dimou E., Laras A., et al. Course of virologic breakthroughs under long-term lamivudine in HBeAg-negative precore mutant HBV liver disease. Hepatology 36 (2002) 219-226
5. Rizzetto M., Tassopoulos N., Goldin R., et al. Extended lamivudine treatment in patients with HBeAg-negative chronic hepatitis B. J Hepatol 42 (2005) 173-179
6. Di Marco V., Marzano A., Lampertico P., et al. Clinical outcome of HBeAg-negative chronic hepatitis B in relation to virological response to lamivudine. Hepatology 40 (2004) 883-891
7. Perrillo R., Hann H., Mutimer D., et al. Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus. Gastroenterology 126 (2004) 81-90
8. Peters M., Hann H., Martin P., et al. Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B. Gastroenterology 126 (2004) 91-101
9. Schiff E., Lai C., Hadziyannis S., et al. Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre- and post-liver transplantation patients. Hepatology 38 (2003) 1419-1427
10. Vassiliadis T., Nikolaidis N., Giouleme O., et al. Adefovir dipivoxil added to ongoing lamivudine therapy in patients with lamivudine-resistant hepatitis B e antigen-negative chronic hepatitis B. Aliment Pharmacol Ther 21 (2005) 531-537
11. Marcellin P., Chang T., Lim S., et al. Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B. N Engl J Med 348 (2003) 808-816
12. Hadziyannis S., Tassopoulos N., Heathcote E., et al. Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B. N Engl J Med 348 (2003) 800-807
13. Knodell R., Ishak K., Black W., et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatolog/ 1 (1981) 431-435
14. Perrillo R., Schiff E., Davis G., et al., Hepatitis Interventional Therapy Group. A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. N Engl J Med 323 (1990) 295-301
15. Shaw T., Bowden S., and Locarnini S. Rescue therapy for drug resistant hepatitis B: Another argument for combination chemotherapy?. Gastroenterology 126 (2004) 343-347
16. Hadziyannis S., Tassopoulos N., Heathcote E., et al. Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B. N Engl J Med 352 (2005) 2673-2681
17. Shaw T., Bartholomeusz A., and Locarnini S. HBV drug resistance: Mechanisms, detection and interpretation. J Hepatol 44 (2006) 593-606